Skip to content

Insider · CIK 0001376099

Jack Kaye

director

Files at DYAI (DYADIC INTERNATIONAL INC), QURE (uniQure N.V.). First filing Jun 24, 2025, latest Jul 2, 2026.

In brief

Jack Kaye files SEC Form 4 as director at QURE (uniQure N.V.), and also at DYAI (DYADIC INTERNATIONAL INC). Since Jun 24, 2025, Jack Kaye has reported 0 open-market buys worth $0 and 7 open-market sells worth $2.7M, the latest filed on Jul 2, 2026.

A track record needs three past buys with six months of prices behind them; Jack Kaye has 0, so none is measured yet.

The newest scored trade: sold $983k of QURE on Jun 30, 2026, filed Jul 2, 2026, scored 40 (moderate), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 6 sells worth $2.7M.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 7
$0 bought, $2.7M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

QURE: uniQure N.V.

QUREOct 9, 2026 · close 22.59

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
40Moderate
QUREsell 410b5-1
uniQure N.V.
$983k
21,167 shares
-70%+410% from low-35% from high
13Weak
QUREsell 1110b5-1
uniQure N.V.
$225k
5,295 shares
-17%+433% from low-32% from high
37Weak
QUREsell 10
uniQure N.V.
$54k
1,993 shares
-7%+197% from low-62% from high
9Weak
QUREsell 1010b5-1
uniQure N.V.
$79k
2,645 shares
-11%+231% from low-58% from high
4Weak
QUREsell 210b5-1
uniQure N.V.
$174k
6,390 shares
-24%+204% from low-64% from high
33Weak
QUREsell 210b5-1
uniQure N.V.
$1.2M
38,810 shares
-128%+447% from low-57% from high
35Weak
QUREsell 9
uniQure N.V.
$31k
2,112 shares
-9%+213% from low-21% from high

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Jun 30, 2026 QURE
uniQure N.V.
21,167
0.03% of outstanding
$983kJun 30, 2026$359k
Jun 17, 2026 QURE
uniQure N.V.
5,295
0.01% of outstanding
$225kJun 17, 2026$133k
Jun 11, 2026 QURE
uniQure N.V.
1,993
0.00% of outstanding
$54kJun 11, 2026$79k
Jun 3, 2026 QURE
uniQure N.V.
2,645
0.00% of outstanding
$79kJun 3, 2026none
Jan 9, 2026 QURE
uniQure N.V.
6,390
0.01% of outstanding
$174kJan 9, 2026$1.2M
Nov 4, 2025 QURE
uniQure N.V.
38,810
0.06% of outstanding
$1.3MNov 4, 2025none

Transactions

Every row this insider has filed, 43 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 30, 2026QURE
uniQure N.V.
MOption exercise
Ordinary Shares10b5-1
+4,107$37.00$152k30,103Jul 2, 2026
Jun 30, 2026QURE
uniQure N.V.
SOpen-market sale
Ordinary Shares10b5-1
-4,107$46.49$191k25,996Jul 2, 2026
Jun 30, 2026QURE
uniQure N.V.
MOption exercise
Ordinary Shares10b5-1
+17,060$20.18$344k43,056Jul 2, 2026
Jun 30, 2026QURE
uniQure N.V.
SOpen-market sale
Ordinary Shares10b5-1
-17,060$46.43$792k25,996Jul 2, 2026
Jun 30, 2026QURE
uniQure N.V.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-4,107$0.00$00Jul 2, 2026
Jun 30, 2026QURE
uniQure N.V.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-17,060$0.00$00Jul 2, 2026
Jun 17, 2026QURE
uniQure N.V.
MOption exercise
Ordinary Shares10b5-1
+5,295$31.71$168k31,291Jun 22, 2026
Jun 17, 2026QURE
uniQure N.V.
SOpen-market sale
Ordinary Shares10b5-1
-5,295$42.57$225k25,996Jun 22, 2026
Jun 17, 2026QURE
uniQure N.V.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-5,295$0.00$00Jun 22, 2026
Jun 10, 2026QURE
uniQure N.V.
AGrant or award
Ordinary Shares
+7,550$0.00$027,989Jun 12, 2026
Jun 11, 2026QURE
uniQure N.V.
SOpen-market sale
Ordinary Shares
-1,993$27.06$54k25,996Jun 12, 2026
Jun 10, 2026QURE
uniQure N.V.
AGrant or award
Stock Option (Right to Buy)derivative
+13,980$0.00$013,980Jun 12, 2026
Jun 3, 2026QURE
uniQure N.V.
MOption exercise
Ordinary Shares10b5-1
+2,645$16.04$42k23,084Jun 5, 2026
Jun 3, 2026QURE
uniQure N.V.
SOpen-market sale
Ordinary Shares10b5-1
-2,645$30.01$79k20,439Jun 5, 2026
Jun 3, 2026QURE
uniQure N.V.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-2,645$0.00$00Jun 5, 2026
Jan 9, 2026QURE
uniQure N.V.
MOption exercise
Ordinary Shares10b5-1
+6,390$19.39$124k26,829Jan 12, 2026
Jan 9, 2026QURE
uniQure N.V.
SOpen-market sale
Ordinary Shares10b5-1
-6,390$27.28$174k20,439Jan 12, 2026
Jan 9, 2026QURE
uniQure N.V.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-6,390$0.00$00Jan 12, 2026
Jan 2, 2026DYAI
DYADIC INTERNATIONAL INC
MOption exercise
Common Stock
+21,552--81,201Jan 6, 2026
Jan 2, 2026DYAI
DYADIC INTERNATIONAL INC
MOption exercise
Restricted Stock Unitderivative
-21,552$0.00$00Jan 6, 2026
Jan 2, 2026DYAI
DYADIC INTERNATIONAL INC
AGrant or award
Stock Optionderivative
+67,500$0.00$067,500Jan 6, 2026
Jan 2, 2026DYAI
DYADIC INTERNATIONAL INC
AGrant or award
Restricted Stock Unitderivative
+39,894$0.00$039,894Jan 6, 2026
Nov 4, 2025QURE
uniQure N.V.
MOption exercise
Ordinary Shares10b5-1
+10,000$7.37$74k30,439Nov 6, 2025
Nov 4, 2025QURE
uniQure N.V.
SOpen-market sale
Ordinary Shares10b5-1
-10,000$30.36$304k20,439Nov 6, 2025
Nov 4, 2025QURE
uniQure N.V.
MOption exercise
Ordinary Shares10b5-1
+11,000$5.37$59k31,439Nov 6, 2025
Nov 4, 2025QURE
uniQure N.V.
SOpen-market sale
Ordinary Shares10b5-1
-11,000$30.34$334k20,439Nov 6, 2025
Nov 4, 2025QURE
uniQure N.V.
MOption exercise
Ordinary Shares10b5-1
+17,810$14.08$251k38,249Nov 6, 2025
Nov 4, 2025QURE
uniQure N.V.
SOpen-market sale
Ordinary Shares10b5-1
-17,810$30.33$540k20,439Nov 6, 2025
Nov 4, 2025QURE
uniQure N.V.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-10,000$0.00$00Nov 6, 2025
Nov 4, 2025QURE
uniQure N.V.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-11,000$0.00$00Nov 6, 2025
Nov 4, 2025QURE
uniQure N.V.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-17,810$0.00$00Nov 6, 2025
Jun 20, 2025QURE
uniQure N.V.
SOpen-market sale
Ordinary Shares
-2,112$14.45$31k20,439Jun 24, 2025
Jun 11, 2025QURE
uniQure N.V.
AGrant or award
Ordinary Shares
+7,970$0.00$022,551Jun 13, 2025
Jun 11, 2025QURE
uniQure N.V.
AGrant or award
Stock Option (Right to Buy)derivative
+15,630$0.00$015,630Jun 13, 2025
Mar 5, 2025DYAI
DYADIC INTERNATIONAL INC
MOption exercise
Common Stock
+7,500$1.33$9,97564,666Mar 7, 2025
Mar 5, 2025DYAI
DYADIC INTERNATIONAL INC
MOption exercise
Common Stock
+22,500$1.33$30k87,166Mar 7, 2025
Mar 5, 2025DYAI
DYADIC INTERNATIONAL INC
FTax withholding
Common Stock
-27,517$1.45$40k59,649Mar 7, 2025
Mar 5, 2025DYAI
DYADIC INTERNATIONAL INC
MOption exercise
Stock Optionderivative
-7,500$0.00$00Mar 7, 2025
Mar 5, 2025DYAI
DYADIC INTERNATIONAL INC
MOption exercise
Stock Optionderivative
-22,500$0.00$00Mar 7, 2025
Jan 2, 2025DYAI
DYADIC INTERNATIONAL INC
MOption exercise
Common Stock
+23,585--57,166Jan 7, 2025
Jan 2, 2025DYAI
DYADIC INTERNATIONAL INC
MOption exercise
Restricted Stock Unitderivative
-23,585$0.00$00Jan 7, 2025
Jan 2, 2025DYAI
DYADIC INTERNATIONAL INC
AGrant or award
Stock Optionderivative
+67,500$0.00$067,500Jan 7, 2025
Jan 2, 2025DYAI
DYADIC INTERNATIONAL INC
AGrant or award
Restricted Stock Unitderivative
+21,552$0.00$021,552Jan 7, 2025

Questions about Jack Kaye

Answered from the filings on this page, as of the latest one.

Is Jack Kaye buying or selling?

In the last 12 months Jack Kaye reported 0 open-market buys worth $0 and 6 open-market sells worth $2.7M on SEC Form 4; the latest was sold $983k of QURE on Jun 30, 2026. Grants, option exercises and tax withholding are not counted.

How did Jack Kaye's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jack Kaye has 0.

Where does Jack Kaye file Form 4?

Jack Kaye has filed Form 4 at QURE (uniQure N.V.); DYAI (DYADIC INTERNATIONAL INC). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jack Kaye: insider trades and track record | InsiderTell